Metropolis Healthcare · NSE: METROPOLIS · BSE: 542650
Q3 FY20 results · Oct–Dec 2019
Metropolis Healthcare reported revenue from operations of ₹222.85 crore and net profit of ₹42.01 crore for Q3 FY20 (Oct–Dec 2019), on a consolidated basis.
| Item | Q3 FY20 | Q3 FY19 | YoY | Q2 FY20 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 222.85 | — | — | 223.28 | −0.2% |
| Other income | 2.19 | — | — | 1.97 | +11.3% |
| Total income | 225.04 | — | — | 225.25 | −0.1% |
| Profit before tax | 52.80 | — | — | 53.40 | −1.1% |
| Net profit for the period | 42.01 | — | — | 43.13 | −2.6% |
| Attributable to shareholders of the company | 42.07 | — | — | 42.98 | −2.1% |
| EPS, basic (₹) | 8.38 | — | — | 8.57 | −2.2% |
| Net margin (%) | 18.9 | — | 19.3 |
| Item | Q3 FY20 | Q3 FY19 | YoY | Q2 FY20 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 172.91 | — | — | 172.28 | +0.4% |
| Other income | 1.78 | — | — | 0.98 | +81.3% |
| Total income | 174.69 | — | — | 173.27 | +0.8% |
| Profit before tax | 39.99 | — | — | 38.09 | +5.0% |
| Net profit for the period | 32.30 | — | — | 31.68 | +2.0% |
| EPS, basic (₹) | 6.44 | — | — | 6.31 | +2.1% |
| Net margin (%) | 18.7 | — | 18.4 |
Consolidated
- Filed with BSE
- 08 Feb 2020, 16:05 IST
- Board meeting
- 06 Feb 2020
- Period
- 01 Oct 2019 to 31 Dec 2019
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 08 Feb 2020, 16:05 IST
- Board meeting
- 06 Feb 2020
- Period
- 01 Oct 2019 to 31 Dec 2019
- Review status
- Unaudited
- Source
- XBRL filing on BSE